10x Genomics Inc. (TXG)
NASDAQ · Healthcare
10x Genomics Inc. Operating Income 2017–2025
10x Genomics Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- 10x Genomics Inc. operating income for the quarter ending March 31, 2026 was -17.0 M, a 56.66% decrease year-over-year.
- 10x Genomics Inc. operating income for the twelve months ending March 31, 2026 was -58.5 M, a 75.58% decrease year-over-year.
- 10x Genomics Inc. annual operating income for 2025 was -61.0 M, a 68.65% decrease from 2024.
- 10x Genomics Inc. annual operating income for 2024 was -194.6 M, a 26.67% decrease from 2023.
- 10x Genomics Inc. annual operating income for 2023 was -265.3 M, a 57.99% increase from 2022.
- 10x Genomics Inc. annual operating income for 2022 was -167.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
10x Genomics Inc. Operating Income — FAQ
10x Genomics Inc. (TXG) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is 10x Genomics Inc.'s operating income?
10x Genomics Inc. (TXG) reported operating income of -$61M for fiscal 2025.
Where can I see TXG's operating income history?
The chart and table above show 10x Genomics Inc.'s operating income by year and by quarter, including the growth rate.